darunavir has been researched along with l 739594 in 2 studies
| Studies (darunavir) | Trials (darunavir) | Recent Studies (post-2010) (darunavir) | Studies (l 739594) | Trials (l 739594) | Recent Studies (post-2010) (l 739594) |
|---|---|---|---|---|---|
| 1,148 | 224 | 780 | 5 | 0 | 0 |
| Protein | Taxonomy | darunavir (IC50) | l 739594 (IC50) |
|---|---|---|---|
| Gag-Pol polyprotein | Human immunodeficiency virus type 1 (NEW YORK-5 ISOLATE) | 0.0018 | |
| Protease | Human immunodeficiency virus 1 | 0.0669 | |
| Protease | Human immunodeficiency virus 1 | 0.0018 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dawson, ZL; Ghosh, AK; Mitsuya, H | 1 |
| Ghosh, AK | 1 |
2 review(s) available for darunavir and l 739594
| Article | Year |
|---|---|
Darunavir, a conceptually new HIV-1 protease inhibitor for the treatment of drug-resistant HIV.
Topics: Clinical Trials as Topic; Crystallography, X-Ray; Darunavir; Drug Design; Drug Resistance, Viral; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Ligands; Molecular Structure; Structure-Activity Relationship; Sulfonamides | 2007 |
Harnessing nature's insight: design of aspartyl protease inhibitors from treatment of drug-resistant HIV to Alzheimer's disease.
Topics: Alzheimer Disease; Amyloid Precursor Protein Secretases; Animals; Antiviral Agents; Aspartic Acid Endopeptidases; Biological Products; Darunavir; Drug Design; Drug Discovery; Drug Resistance, Viral; Enzyme Inhibitors; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Molecular Mimicry; Molecular Structure; Peptides; Structure-Activity Relationship; Sulfonamides | 2009 |